Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2006) | Total Docs. (3years) | Total Refs. (2006) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2006) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Natural Product Reports | journal | 2.753 Q1 | 211 | 53 | 128 | 9245 | 950 | 123 | 7.73 | 174.43 |  |
| 2 | Critical Reviews in Toxicology | journal | 1.537 Q1 | 129 | 29 | 69 | 4381 | 317 | 63 | 3.80 | 151.07 | |
| 3 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.446 Q1 | 99 | 24 | 48 | 3594 | 210 | 45 | 4.00 | 149.75 | |
| 4 | Expert Opinion on Emerging Drugs | journal | 0.708 Q2 | 54 | 46 | 116 | 5338 | 331 | 116 | 3.06 | 116.04 | |
| 5 | Toxicological Reviews | journal | 0.695 Q2 | 49 | 20 | 75 | 2097 | 178 | 67 | 1.71 | 104.85 | |
| 6 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.319 Q3 | 100 | 69 | 51 | 6961 | 76 | 51 | 1.49 | 100.88 | |
| 7 | Expert Opinion on Biological Therapy | journal | 0.910 Q2 | 102 | 118 | 426 | 10116 | 1358 | 420 | 3.26 | 85.73 | |
| 8 | Expert Opinion on Therapeutic Targets | journal | 1.268 Q1 | 106 | 84 | 204 | 7122 | 651 | 195 | 3.07 | 84.79 | |
| 9 | Expert Opinion on Drug Delivery | journal | 0.588 Q1 | 133 | 65 | 97 | 5359 | 207 | 93 | 2.13 | 82.45 | |
| 10 | Expert Opinion on Investigational Drugs | journal | 1.075 Q1 | 117 | 138 | 426 | 11102 | 1507 | 414 | 3.45 | 80.45 | |
| 11 | Expert Review of Vaccines | journal | 0.810 Q2 | 105 | 76 | 265 | 6009 | 679 | 243 | 2.24 | 79.07 | |
| 12 | Expert Opinion on Pharmacotherapy | journal | 0.565 Q2 | 93 | 226 | 676 | 15502 | 1536 | 663 | 2.27 | 68.59 | |
| 13 | Clinical Pharmacokinetics | journal | 1.534 Q1 | 184 | 82 | 241 | 5255 | 1530 | 238 | 5.41 | 64.09 | |
| 14 | Expert Opinion on Drug Discovery | journal | 84 | 65 | 0 | 4028 | 0 | 0 | 0.00 | 61.97 | | |
| 15 | Expert Opinion on Therapeutic Patents | journal | 0.456 Q3 | 88 | 117 | 362 | 7106 | 494 | 350 | 1.53 | 60.74 | |
| 16 | BioDrugs | journal | 0.786 Q2 | 79 | 42 | 125 | 2488 | 383 | 123 | 3.70 | 59.24 | |
| 17 | Toxin Reviews | journal | 0.242 Q3 | 54 | 29 | 90 | 1716 | 84 | 83 | 0.96 | 59.17 | |
| 18 | Chinese Medicine | journal | 56 | 4 | 0 | 235 | 0 | 0 | 0.00 | 58.75 | | |
| 19 | Current Opinion in Investigational Drugs | journal | 1.120 Q1 | 83 | 132 | 484 | 7673 | 1527 | 446 | 3.01 | 58.13 | |
| 20 | Current Opinion in Drug Discovery and Development | journal | 1.404 Q1 | 85 | 67 | 245 | 3875 | 1246 | 229 | 5.43 | 57.84 | |
| 21 | Neuropsychopharmacology | journal | 2.724 Q1 | 249 | 285 | 762 | 16343 | 4804 | 734 | 6.33 | 57.34 | |
| 22 | Current Opinion in Molecular Therapeutics | journal | 0.908 Q2 | 67 | 69 | 270 | 3935 | 701 | 241 | 2.55 | 57.03 | |
| 23 | Drug Safety | journal | 1.352 Q1 | 140 | 93 | 262 | 5283 | 1202 | 245 | 4.54 | 56.81 | |
| 24 | Molecular Diagnosis and Therapy | journal | 68 | 43 | 186 | 2421 | 548 | 184 | 2.88 | 56.30 | | |
| 25 | Particle and Fibre Toxicology | journal | 1.458 Q1 | 119 | 16 | 14 | 852 | 74 | 13 | 5.29 | 53.25 | |
| 26 | Trends in Pharmacological Sciences | journal | 4.402 Q1 | 244 | 104 | 356 | 5460 | 3669 | 324 | 10.55 | 52.50 | |
| 27 | Xenobiotica | journal | 0.512 Q3 | 89 | 71 | 242 | 3596 | 475 | 242 | 1.93 | 50.65 | |
| 28 | Drugs in R and D | journal | 0.377 Q3 | 54 | 37 | 190 | 1816 | 244 | 190 | 1.49 | 49.08 | |
| 29 | Drug Discovery Today | journal | 1.251 Q1 | 215 | 161 | 1060 | 7603 | 3278 | 847 | 3.22 | 47.22 | |
| 30 | Neuropharmacology | journal | 1.921 Q1 | 191 | 229 | 730 | 10800 | 3166 | 727 | 4.37 | 47.16 | |
| 31 | American Journal of Drug Delivery | journal | 0.329 Q3 | 23 | 28 | 41 | 1319 | 36 | 39 | 0.88 | 47.11 | |
| 32 | Tetrahedron | journal | 1.524 Q1 | 236 | 1309 | 3497 | 60611 | 10440 | 3480 | 2.95 | 46.30 | |
| 33 | Personalized Medicine | journal | 36 | 42 | 0 | 1935 | 0 | 0 | 0.00 | 46.07 | | |
| 34 | Fundamental and Clinical Pharmacology | journal | 0.733 Q2 | 85 | 61 | 233 | 2803 | 624 | 231 | 2.37 | 45.95 | |
| 35 | Drug Discovery Today: Therapeutic Strategies | journal | 0.359 Q3 | 31 | 86 | 129 | 3896 | 117 | 122 | 0.91 | 45.30 | |
| 36 | Journal of Psychopharmacology | journal | 1.183 Q1 | 135 | 144 | 275 | 6477 | 851 | 238 | 3.09 | 44.98 | |
| 37 | Nature Reviews Drug Discovery | journal | 7.332 Q1 | 391 | 162 | 916 | 7271 | 5779 | 265 | 5.58 | 44.88 | |
| 38 | Drug Discovery Today: Disease Mechanisms | journal | 0.242 Q4 | 28 | 74 | 146 | 3305 | 74 | 134 | 0.51 | 44.66 | |
| 39 | Toxicological Sciences | journal | 1.327 Q1 | 207 | 333 | 894 | 14700 | 3449 | 860 | 3.83 | 44.14 | |
| 40 | SAR and QSAR in Environmental Research | journal | 0.411 Q3 | 54 | 37 | 111 | 1616 | 235 | 111 | 2.27 | 43.68 | |
| 41 | Clinical and Experimental Pharmacology and Physiology | journal | 0.695 Q2 | 115 | 206 | 510 | 8842 | 1002 | 501 | 1.84 | 42.92 | |
| 42 | Pharmacogenomics Journal | journal | 1.357 Q1 | 95 | 54 | 158 | 2304 | 673 | 139 | 4.74 | 42.67 | |
| 43 | Journal of Clinical Research | journal | 0.640 Q2 | 12 | 2 | 7 | 85 | 13 | 7 | 2.60 | 42.50 | |
| 44 | Mutagenesis | journal | 0.947 Q1 | 102 | 56 | 205 | 2367 | 587 | 201 | 2.52 | 42.27 | |
| 45 | Toxicology Mechanisms and Methods | journal | 0.220 Q3 | 55 | 67 | 131 | 2826 | 87 | 130 | 0.59 | 42.18 | |
| 46 | Pharmacogenomics | journal | 0.939 Q2 | 100 | 115 | 282 | 4762 | 853 | 244 | 3.40 | 41.41 | |
| 47 | ChemMedChem | journal | 0.341 Q2 | 119 | 145 | 441 | 5995 | 562 | 439 | 1.18 | 41.34 | |
| 48 | Journal of Drug Targeting | journal | 0.727 Q1 | 107 | 78 | 194 | 3224 | 481 | 184 | 2.38 | 41.33 | |
| 49 | Food and Chemical Toxicology | journal | 0.884 Q2 | 203 | 230 | 558 | 9464 | 1683 | 548 | 2.92 | 41.15 | |
| 50 | International Journal of Neuroprotection and Neuroregeneration | journal | 5 | 26 | 0 | 1066 | 0 | 0 | 0.00 | 41.00 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data